Tag: Torrent Pharmaceuticals
Torrent Pharmaceuticals to co-market Saroglitazar Mg with Zydus for liver health
Torrent Pharmaceuticals Limited and Zydus Lifesciences Limited announced a significant licensing and supply agreement to co-market Saroglitazar Mg, a drug for treating Non-Alcoholic Steato Hepatitis ... Read More
Torrent Pharmaceuticals Q1 FY24 snapshot: 10% surge in revenue amid resilient Germany performance
Torrent Pharmaceuticals, a key player in the pharmaceutical landscape, has publicized its financial figures for Q1 FY24, showcasing a solid 10% revenue growth, touching Rs. ... Read More
Torrent Pharmaceuticals wraps up Rs 20bn acquisition of Curatio Healthcare
Torrent Pharmaceuticals said that it has wrapped up the previously announced INR 2,000 crores acquisition of Curatio Healthcare (I) Private Limited, a cosmetic dermatology company. ... Read More
Torrent Pharmaceuticals to acquire dermatology company Curatio Healthcare for Rs 20bn
Indian pharma company Torrent Pharmaceuticals has agreed to acquire cosmetic dermatology company Curatio Healthcare (I) Private Limited for INR 2,000 crores, in a move to ... Read More
Torrent Pharma buys Styptovit-E, Finast, and other brands from Dr. Reddy’s
Torrent Pharmaceuticals has agreed to acquire the Styptovit-E, Finast, Finast-T, and Dynapress brands from Dr. Reddy's Laboratories for an undisclosed price. Styptovit-E is a gynecology ... Read More
Torrent Pharmaceuticals gets rights to generic of Pfizer’s oral Covid-19 treatment
Torrent Pharmaceuticals has entered into a licensing agreement with Medicine Patent Pool (MPP) for manufacturing and commercializing the generic version of Pfizer’s oral Covid-19 treatment. ... Read More
Cipla, Dr. Reddy’s, and others to collaborate on Molnupiravir Covid trial
Five Indian pharma companies – Cipla, Dr. Reddy’s Laboratories, Emcure Pharmaceuticals, Sun Pharmaceutical Industries, and Torrent Pharmaceuticals will join forces to undertake a clinical trial ... Read More